Case study: Using A continuous glucose monitoring system in A patient with diabetes and beta-thalassemia hemoglobinopathy

Abdulla Al-Futaisi, Yasser Wali, Ismail El-Beshlawi, Shaden Al-Riyami, Abdulaziz Almahrezi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Optimum glycemic control is extremely important in patients with diabetes mellitus to avoid long-term complications. Glycemic control relies mainly on the use of hemoglobin A1c, which unfortunately showed inaccurate results in patients with hemoglinopathies. The authors describe a case of β-thalassemia with poorly controlled diabetes mellitus that has misleading low levels of HbA1c. The use of a continuous glucose monitoring system was useful in documenting her poor glycemic control, with prolonged periods of hyper- and hypoglycemia. Based on these results, her insulin regimen was adjusted and the blood glucose levels were greatly improved throughout and the patient was able to meet her target blood glucose range (72-140 mg/dL 4-7.8 mmol/L) in 70% of the time.

Original languageEnglish
Pages (from-to)515-519
Number of pages5
JournalPediatric Hematology and Oncology
Volume26
Issue number7
DOIs
Publication statusPublished - 2009

Fingerprint

Hemoglobinopathies
beta-Thalassemia
Glucose
Blood Glucose
Diabetes Mellitus
Thalassemia
Hypoglycemia
Hyperglycemia
Hemoglobins
Insulin

Keywords

  • CGMS
  • Diabetes
  • Thalassemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Case study : Using A continuous glucose monitoring system in A patient with diabetes and beta-thalassemia hemoglobinopathy. / Al-Futaisi, Abdulla; Wali, Yasser; El-Beshlawi, Ismail; Al-Riyami, Shaden; Almahrezi, Abdulaziz.

In: Pediatric Hematology and Oncology, Vol. 26, No. 7, 2009, p. 515-519.

Research output: Contribution to journalArticle

@article{afc6b23a2c674e1684f31afb2c3ea446,
title = "Case study: Using A continuous glucose monitoring system in A patient with diabetes and beta-thalassemia hemoglobinopathy",
abstract = "Optimum glycemic control is extremely important in patients with diabetes mellitus to avoid long-term complications. Glycemic control relies mainly on the use of hemoglobin A1c, which unfortunately showed inaccurate results in patients with hemoglinopathies. The authors describe a case of β-thalassemia with poorly controlled diabetes mellitus that has misleading low levels of HbA1c. The use of a continuous glucose monitoring system was useful in documenting her poor glycemic control, with prolonged periods of hyper- and hypoglycemia. Based on these results, her insulin regimen was adjusted and the blood glucose levels were greatly improved throughout and the patient was able to meet her target blood glucose range (72-140 mg/dL 4-7.8 mmol/L) in 70{\%} of the time.",
keywords = "CGMS, Diabetes, Thalassemia",
author = "Abdulla Al-Futaisi and Yasser Wali and Ismail El-Beshlawi and Shaden Al-Riyami and Abdulaziz Almahrezi",
year = "2009",
doi = "10.1080/08880010902975892",
language = "English",
volume = "26",
pages = "515--519",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Case study

T2 - Using A continuous glucose monitoring system in A patient with diabetes and beta-thalassemia hemoglobinopathy

AU - Al-Futaisi, Abdulla

AU - Wali, Yasser

AU - El-Beshlawi, Ismail

AU - Al-Riyami, Shaden

AU - Almahrezi, Abdulaziz

PY - 2009

Y1 - 2009

N2 - Optimum glycemic control is extremely important in patients with diabetes mellitus to avoid long-term complications. Glycemic control relies mainly on the use of hemoglobin A1c, which unfortunately showed inaccurate results in patients with hemoglinopathies. The authors describe a case of β-thalassemia with poorly controlled diabetes mellitus that has misleading low levels of HbA1c. The use of a continuous glucose monitoring system was useful in documenting her poor glycemic control, with prolonged periods of hyper- and hypoglycemia. Based on these results, her insulin regimen was adjusted and the blood glucose levels were greatly improved throughout and the patient was able to meet her target blood glucose range (72-140 mg/dL 4-7.8 mmol/L) in 70% of the time.

AB - Optimum glycemic control is extremely important in patients with diabetes mellitus to avoid long-term complications. Glycemic control relies mainly on the use of hemoglobin A1c, which unfortunately showed inaccurate results in patients with hemoglinopathies. The authors describe a case of β-thalassemia with poorly controlled diabetes mellitus that has misleading low levels of HbA1c. The use of a continuous glucose monitoring system was useful in documenting her poor glycemic control, with prolonged periods of hyper- and hypoglycemia. Based on these results, her insulin regimen was adjusted and the blood glucose levels were greatly improved throughout and the patient was able to meet her target blood glucose range (72-140 mg/dL 4-7.8 mmol/L) in 70% of the time.

KW - CGMS

KW - Diabetes

KW - Thalassemia

UR - http://www.scopus.com/inward/record.url?scp=70350072832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350072832&partnerID=8YFLogxK

U2 - 10.1080/08880010902975892

DO - 10.1080/08880010902975892

M3 - Article

C2 - 19863207

AN - SCOPUS:70350072832

VL - 26

SP - 515

EP - 519

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 7

ER -